Breakdown | ||||
Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
1.37T | 1.41T | 1.28T | 1.02T | 813.33B | Gross Profit |
428.64B | 435.17B | 377.95B | 279.99B | 193.34B | EBIT |
144.99B | 168.03B | 133.31B | 106.59B | 28.23B | EBITDA |
160.93B | 245.81B | 200.28B | 159.44B | 83.81B | Net Income Common Stockholders |
81.43B | 93.29B | 70.17B | 75.83B | 10.34B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
147.14B | 143.53B | 141.85B | 119.52B | 96.50B | Total Assets |
1.79T | 1.89T | 1.63T | 1.41T | 1.22T | Total Debt |
610.42B | 649.82B | 579.26B | 414.54B | 388.92B | Net Debt |
463.29B | 506.29B | 467.27B | 320.28B | 308.59B | Total Liabilities |
933.05B | 1.07T | 925.96B | 741.63B | 651.33B | Stockholders Equity |
809.34B | 763.38B | 659.99B | 611.61B | 514.29B |
Cash Flow | Free Cash Flow | |||
111.58B | 17.43B | -85.28B | 4.78B | 58.13B | Operating Cash Flow |
143.93B | 73.03B | -26.14B | 39.32B | 91.34B | Investing Cash Flow |
-56.46B | -39.03B | -42.65B | -6.85B | -32.28B | Financing Cash Flow |
-81.75B | -8.92B | 87.09B | -25.61B | -46.01B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
$6.54B | 12.28 | 9.99% | 3.75% | ― | ― | ||
66 Neutral | $4.51B | 12.29 | 5.40% | 248.53% | 4.14% | -12.41% | |
$12.80B | 10.42 | 8.29% | 2.79% | ― | ― | ||
€746.71M | 14.75 | 4.46% | 2.37% | ― | ― | ||
79 Outperform | ¥4.13T | 9.44 | 4.25% | 5.97% | 13.78% | ||
¥217.21B | 8.25 | 4.39% | ― | ― | |||
65 Neutral | ¥225.83B | 26.03 | 1.13% | -5.15% | -68.51% |